Pricing Log in Create free account

Iterum Therapeutics PLC (ITRMF) vs Silo Pharma, Inc. (SILO)

Iterum Therapeutics PLC and Silo Pharma, Inc. are both Biotechnology companies. Silo Pharma, Inc. is the larger, with a market value of $1.9M against $1.6M — 1.2× the size. Silo Pharma, Inc. has the higher net margin (0.00% vs −2,930.5%) and the higher return on invested capital (0.00% vs −455.5%). Across the 14 metrics below, Silo Pharma, Inc. leads on 9 and Iterum Therapeutics PLC on 5.

Valuation

Metric ITRMF SILO Biotechnology median
P/E n/m n/m 8.50
P/S n/m 18.00 9.71
P/B n/m 0.27 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.90 0.64
EV/Sales 24.37 (54.56) 9.21
Earnings yield 0.00% (369.34%) (33.15%)
Free cash flow yield 0.00% (302.55%) (25.50%)

Profitability

Metric ITRMF SILO Biotechnology median
Gross margin (81.85%) 11.81% 65.16%
Operating margin (2,243.48%) 0.00% 0.00%
Net margin (2,930.54%) 0.00% 0.00%
Free cash flow margin (2,122.61%) 0.00% 0.00%
Return on equity 285.48% (91.23%) (56.36%)
Return on assets (111.35%) (70.96%) (48.04%)
Return on invested capital (455.51%) 0.00% 0.00%

Growth

Metric ITRMF SILO Biotechnology median
Revenue growth (TTM) — 0.00% 6.02%
EPS growth (last fiscal year) 57.43% 57.98% 30.26%
Revenue growth, 5-year CAGR — 12.17% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ITRMF SILO Biotechnology median
Debt to equity (2.87) 0.00 0.00
Current ratio 2.13 5.36 4.72
Net debt to EBITDA 0.24 1.61 0.96

Dividend

Metric ITRMF SILO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ITRMF SILO Biotechnology median
Market cap 1.59m 1.91m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack